ENTITY

Five Prime Therapeutics (FPRX US)

Health Care • United States

Five Prime Therapeutics, Inc. provides clinical stage biotechnology services. The Company offers innovative protein and antibody therapeutics, as well as offers drugs for oncology and immunology diseases. FivePrime Therapeutics conducts serves customers in the United States.

Refresh

Focused

No publications yet

Add Five Prime Therapeutics to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00